Sarepta Therapeutics, Inc. (BMV:SRPT)

Sarepta Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	240.87	1,103	428.43	966.78	2,116	1,503
Short-Term Investments	281.9	251.78	1,248	1,023	-	435.92
Cash & Short-Term Investments	522.76	1,355	1,676	1,989	2,116	1,939
Cash Growth	-62.41%	-19.18%	-15.74%	-5.98%	9.15%	72.36%
Accounts Receivable	714.59	636.6	430.11	256.39	171.64	135.52
Other Receivables	9.94	13.13	6.86	5.21	0.01	3.06
Receivables	724.52	649.73	436.98	261.6	171.65	138.58
Inventory	941.43	749.96	322.86	203.97	186.21	231.96
Prepaid Expenses	29.31	30.67	27.64	29.64	30.31	32.65
Other Current Assets	214.51	288.32	115.61	73.28	100.06	143.43
Total Current Assets	2,433	3,073	2,579	2,558	2,604	2,485
Property, Plant & Equipment	507.65	488.65	357.11	244.99	236.69	282.19
Long-Term Investments	263.5	136.87	6.53	31.32	34.89	38.8
Other Intangible Assets	26.2	26.89	29.62	7.58	14.24	13.63
Other Long-Term Assets	235.51	237.3	291.99	286.62	258.06	164.9
Total Assets	3,465	3,963	3,265	3,128	3,148	2,985
Accounts Payable	156.11	214.44	164.92	95.88	76.74	111.09
Accrued Expenses	178.77	241.66	197.93	335.67	206.45	147.42
Current Portion of Long-Term Debt	-	-	105.48	-	-	-
Current Portion of Leases	12.97	13.27	-	15.49	-	-
Current Income Taxes Payable	79.86	17.39	13.77	12.52	0.22	-
Current Unearned Revenue	44.86	130.26	50.42	89.24	89.24	89.24
Other Current Liabilities	133.01	114.66	121.15	70.8	80.08	68.27
Total Current Liabilities	605.59	731.68	653.66	619.6	452.73	416.03
Long-Term Debt	1,138	1,137	1,133	1,544	1,097	992.49
Long-Term Leases	205.46	192.47	140.97	57.58	41.51	80.37
Long-Term Unearned Revenue	325	325	437	485	574.24	663.49
Other Long-Term Liabilities	48.33	49.15	41.1	36.94	54.6	70.59
Total Liabilities	2,323	2,435	2,405	2,743	2,220	2,223
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	5,801	5,739	5,305	4,297	4,135	3,610
Retained Earnings	-4,658	-4,211	-4,446	-3,910	-3,207	-2,848
Comprehensive Income & Other	0.03	-0.22	0.92	-1.66	-0.02	0
Shareholders' Equity	1,143	1,528	859.34	384.95	928.01	761.76
Total Liabilities & Equity	3,465	3,963	3,265	3,128	3,148	2,985
Total Debt	1,357	1,343	1,379	1,617	1,138	1,073
Net Cash (Debt)	-833.96	11.92	297.29	372.02	977.48	865.71
Net Cash Growth	-	-95.99%	-20.09%	-61.94%	12.91%	119.10%
Net Cash Per Share	-8.69	0.11	3.22	4.25	12.03	11.11
Filing Date Shares Outstanding	98.28	97.03	93.86	87.98	87.15	79.42
Total Common Shares Outstanding	98.25	96.9	93.73	87.95	87.13	79.37
Working Capital	1,827	2,342	1,926	1,938	2,151	2,069
Book Value Per Share	11.63	15.77	9.17	4.38	10.65	9.60
Tangible Book Value	1,117	1,501	829.72	377.37	913.77	748.13
Tangible Book Value Per Share	11.36	15.49	8.85	4.29	10.49	9.43
Land	-	10.17	10.17	5.18	5.18	5.18
Buildings	-	51.18	48.06	47.94	47.61	39.4
Machinery	-	141.98	118.63	102.31	75.04	57.76
Construction In Progress	-	165.9	91.09	23.59	25.16	71.54
Leasehold Improvements	-	155.07	99.99	97.33	103.37	55.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.